Concepedia

Connie Chen

CC

61

Publications

8.7K

Citations

34

H-Index

2002

Active since

Affiliations

Pfizer (United States)(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

University of Chicago Medical Center

Molecular Oncology (United States)

Connie Chen is an author at Pfizer (United States) specializing in medicine, health sciences, and pain medicine.

Top concepts

MedicineHealthOncologyPain MedicinePain ResearchPain ManagementOutcomes ResearchSurgeryAnesthesiologyUrology

Publications per year

2002–2023

61

Publications

61

Postoperative Pain Experience: Results from a National Survey Suggest Postoperative Pain Continues to Be Undermanaged

Jeffrey L. Apfelbaum, Connie Chen, S. Mehta et al. · Anesthesia & Analgesia · 2003 · 2.2K citations

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Brian I. Rini, Bernard Escudier, Piotr Tomczak et al. · The Lancet · 2011 · 1.8K citations

Comparative Effectiveness, Urology, Oncology +7

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

Robert J. Motzer, Bernard Escudier, Piotr Tomczak et al. · The Lancet Oncology · 2013 · 738 citations

Overall Survival Analysis, Urology, Axitinib Versus Sorafenib +7

Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial

Thomas E. Hutson, Vladimir Lesovoy, V.P. Stus et al. · The Lancet Oncology · 2013 · 404 citations

First-line Therapy, Urology, Axitinib Versus Sorafenib +8

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

Kevin Winthrop, Jeffrey R. Curtis, Stephen Lindsey et al. · Arthritis & Rheumatology · 2017 · 232 citations · Full text

Rows per page

1–5 of 61